| |
|
|
Hattori N, Hasegawa K, Sato K, Mitsuyama E, Numachi Y. Clinical evaluation of ropinirole controlled-release formulation at 18-24 mg/day in Japanese patients with Parkinson's disease. Parkinsonism Relat Disord. 40:33-39, 2017 |
|
|
Ando M, Fiesel FC, Hudec R, Caulfield TR, Ogaki K, Górka-Skoczylas P, Koziorowski D, Friedman A, Chen L, Dawson VL, Dawson TM, Bu G, Ross OA, Wszolek ZK, Springer W. The PINK1 p.I368N mutation affects protein stability and ubiquitin kinase activity, Mol Neurodegener, 24: 32, 2017 |
|
|
Cossu D, Yokoyama K, Tomizawa Y, Momotani E, Hattori N. Altered humoral immunity to mycobacterial antigens in Japanese patients affected by inflammatory demyelinating diseases of the central nervous system. Sci Rep. 7:3179, 2017 |
|
|
Daida K, Nishioka K, Li Y, Nakajima S, Tanaka R, Hattori N. CSF1R Mutation p.G589R and the Distribution Pattern of Brain Calcification. Intern Med. 56:2507-2512, 2017
Fujimori K, Matsumoto T, Kisa F, Hattori N, Okano H, Akamatsu W. Escape from Pluripotency via Inhibition of TGF-β/BMP and Activation of Wnt Signaling Accelerates Differentiation and Aging in hPSC Progeny Cells. Stem Cell Reports. 9:1675-1691, 2017 |
|
|
Fukae J, Fujioka S, Yanamoto S, Mori A, Nomi T, Hatano T, Fukuhara K, Ouma S, Hattori N, Tsuboi Y. Serum uric acid level is linked to the disease progression rate in male patients with multiple system atrophy. Clin Neurol Neurosurg. 158:15-19, 2017 |
|
|
Fukuda R, Miyamoto N, Hayashida A, Ueno Y, Yamashiro K, Tanaka R, Hattori N. Acute Hearing Loss Caused by Decreasing Anterior Inferior Cerebellar Arterial Perfusion in a Patient with Vertebral Artery Stenosis. J Stroke Cerebrovasc Dis. 26:e119-e121, 2017 |
|
|
Fukuhara T, Kim J, Hokaiwado S, Nawa M, Okamoto H, Kogiso T, Watabe T, Hattori N. A novel immunotoxin reveals a new role for CD321 in endothelial cells. PLoS One. 12:e0181502, 2017
Goto M, Kamagata K, Hatano T, Hattori N, Abe O, Aoki S, Hori M, Gomi T. Depressive symptoms in Parkinson's disease are related to decreased left hippocampal volume: correlation with the 15-item shortened version of the Geriatric Depression Scale. Acta Radiol. 2017 Jan 1:284185117719100. |
|
|
Hagiwara A, Hori M, Yokoyama K, Nakazawa M, Ueda R, Horita M, Andica C, Abe O, Aoki S. Analysis of White Matter Damage in Patients with Multiple Sclerosis via a Novel In Vivo MR Method for Measuring Myelin, Axons, and G-Ratio, AJNR Am J Neuroradiol. 38:1934-1940, 2017 |
|
|
Hagiwara A, Hori M, Yokoyama K, Takemura MY, Andica C, Kumamaru KK, Nakazawa M, Takano N, Kawasaki H, Sato S, Hamasaki N, Kunimatsu A, Aoki S. Utility of a Multiparametric Quantitative MRI Model That Assesses Myelin and Edema for Evaluating Plaques, Periplaque White Matter, and Normal-Appearing White Matter in Patients with Multiple Sclerosis: A Feasibility Study. AJNR Am J Neuroradiol. 38:237-242, 2017 |
|
|
Hagiwara A, Hori M, Yokoyama K, Takemura MY, Andica C, Tabata T, Kamagata K, Suzuki M, Kumamaru KK, Nakazawa M, Takano N, Kawasaki H, Hamasaki N, Kunimatsu A, Aoki S. Synthetic MRI in the Detection of Multiple Sclerosis Plaques. AJNR Am J Neuroradiol. 38:257-263, 2017 |
|
|
Hara Y, Motoi Y, Hikishima K, Mizuma H, Onoe H, Matsumoto S, Elahi M, Okano H, Aoki S, Hattori N. Involvement of the Septo-Hippocampal Cholinergic Pathway in Association with Septal Acetylcholinesterase Upregulation in a Mouse Model of Tauopathy, Curr Alzheimer Res. 14:94-103, 2017 |
|
|
Hatano T, Daida K, Hoshino Y, Li Y, Saitsu H, Matsumoto N, Hattori N. Dystonia due to bilateral caudate hemorrhage associated with a COL4A1 mutation. Parkinsonism Relat Disord. 40:80-82, 2017 |
|
|
Hatano T, Okuzumi A, Kamagata K, Daida K, Taniguchi D, Hori M, Yoshino H, Aoki S, Hattori N. Neuromelanin MRI is useful for monitoring motor complications in Parkinson's and PARK2 disease. J Neural Transm (Vienna). 124:407-415, 2017 |
|
|
Hosaka Y, Inoshita T, Shiba-Fukushima K, Cui C, Arano T, Imai Y, Hattori N: Reduced TDP-43 Expression Improves Neuronal Activities in a Drosophila Model of Perry Syndrome. EBioMedicine. 21: 218-227, 2017 |
|
|
Ikeda A, Matsushima T, Daida K, Nakajima S, Conedera S, Li Y, Yoshino H, Oyama G, Funayama M, Nishioka K, Hattori N. A novel mutation of CHCHD2 p.R8H in a sporadic case of Parkinson's disease. Parkinsonism Relat Disord. 34:66-68, 2017 |
|
|
Inoshita T, Arano T, Hosaka Y, Meng H, Umezaki Y, Kosugi S, Morimoto T, Koike M, Chang H-Y, Imai Y, Hattori N: Vps35 in cooperation with LRRK2 regulates synaptic vesicle endocytosis through the endosomal pathway in Drosophila. Hum Mol Genet. 26: 2933-2948, 2017 |
|
|
Iwamuro H, Tachibana Y, Ugawa Y, Saito N, Nambu A. Information processing from the motor cortices to the subthalamic nucleus and globus pallidus and their somatotopic organizations revealed electrophysiologically in monkeys. Eur J Neurosci. 46:2684-2701, 2017 |
|
|
Jo T, Yoshimi K, Takahashi T, Oyamaa G, Hattori N. Dual use of rectangular and triangular waveforms in voltammetry using a carbon fiber microelectrode to differentiate norepinephrine from dopamine, Journal of Electroanalytical Chemistry. 802:1-7, 2017 |
|
|
Jurjević I, Miyajima M, Ogino I, Akiba C, Nakajima M, Kondo A, Kikkawa M, Kanai M, Hattori N, Arai H. Decreased Expression of hsa-miR-4274 in Cerebrospinal Fluid of Normal Pressure Hydrocephalus Mimics with Parkinsonian Syndromes. J Alzheimers Dis. 56:317-325, 2017
Kamagata K, Zalesky A, Hatano T, Di Biase MA, Samad OE, Saiki S, Shimoji K, Kumamaru KK, Kamiya K, Hori M, Hattori N, Aoki S, Pantelis C. Connectome Analysis with Diffusion MRI in Idiopathic Parkinson's Disease: Evaluation Using Multi-shell, Multi-tissue, Constrained Spherical Deconvolution. Neuroimage: clinical, 17:518-529, 2017 |
|
|
Kamagata K, Zalesky A, Hatano T, Ueda R, Di Biase MA, Okuzumi A, Shimoji K, Hori M, Caeyenberghs K, Pantelis C, Hattori N, Aoki S. Gray Matter Abnormalities in Idiopathic Parkinson's Disease: Evaluation by Diffusional Kurtosis Imaging and Neurite Orientation Dispersion and Density Imaging. Hum Brain Mapp. 2017 May 4. |
|
|
Kamakura CK, Ueno Y, Sakai Y, Yoshida H, Aiba S, Hayashi A, Shimura H, Takeda K, Kamakura K, Hattori N, Urabe T. White matter lesions and cognitive impairment may be related to recovery from unilateral spatial neglect after stroke. J Neurol Sci. 379:241-246, 2017 |
|
|
Kanai T, Uzawa A, Sato Y, Suzuki S, Kawaguchi N, Himuro K, Oda F, Ozawa Y, Nakahara J, Suzuki N, Takahashi YK, Ishibashi S, Yokota T, Ogawa T, Yokoyama K, Hattori N, Izaki S, Oji S, Nomura K, Kaneko J, Nishiyama K, Yoshino I, Kuwabara S. A clinical predictive score for postoperative myasthenic crisis. Ann Neurol. 82:841-849, 2017 |
|
|
Kitamura N, Seyama K, Inoue Y, Nagai K, Suzuki M, Moriyama H, Takada T, Tazawa R, Hirai T, Mishima M, Hayashida M, Hirose M, Arai T, Sugimoto C, Hattori N, Watanabe K, Tamada T, Akazawa K, Tanaka T, Nakata K. Risk factors for stomatitis in patients with lymphangioleiomyomatosis during treatment with sirolimus: A multicenter investigator-initiated prospective study. Pharmacoepidemiol Drug Saf. 26:1182-1189, 2017 |
|
|
Kobayashi M, Nishioka K, Takanashi M, Hattori A, Shojima Y, Hayashida A, Sumii A, Ota T, Terao Y, Yokoyama K, Hattori N. Anti-NMDA receptor encephalitis due to large-cell neuroendocrine carcinoma of the uterus. J Neurol Sci. 383:72-74, 2017 |
|
|
Maeda T, Shimo Y, Chiu SW, Yamaguchi T, Kashihara K, Tsuboi Y, Nomoto M, Hattori N, Watanabe H, Saiki H; J-FIRST group. Clinical manifestations of nonmotor symptoms in 1021 Japanese Parkinson's disease patients from 35 medical centers. Parkinsonism Relat Disord. 38:54-60, 2017 |
|
 ページの先頭へ |
|
|
Matsuki Y, Miyazaki S. Yoshida K, Ogura A, Sasazawa Y, Takao K, Simizu S. Synthesis and evaluation of biological activities of vibsanin A analogs. Bioorg. Med. Chem. Lett. 27:4536-4539, 2017 |
|
|
Matsushima T, Conedera S, Tanaka R, Li Y, Yoshino H, Funayama M, Ikeda A, Hosaka Y, Okuzumi A, Shimada Y, Yamashiro K, Motoi Y, Nishioka K, Hattori N. Genotype-phenotype correlations of cysteine replacement in CADASIL. Neurobiol Aging. 50:169.e7-169.e14, 2017
Meng H, Yamashita C, Shiba-Fukushima K, Inoshita T, Funayama M, Sato S, Hatta T, Natsume T, Umitsu M, Takagi J, Imai Y, Hattori N: Loss of Parkinson’s disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c. Nat Commun. 8:15500, 2017 |
|
|
Miki Y, Yoshizawa T, Morohashi S, Seino Y, Kijima H, Shoji M, Mori A, Yamashita C, Hatano T, Hattori N, Wakabayashi K. Neuropathology of PARK14 is identical to idiopathic Parkinson's disease. Mov Disord. 32:799-800, 2017 |
|
|
Mishima T, Fujioka S, Tomiyama H, Yabe I, Kurisaki R, Fujii N, Neshige R, Ross OA, Farrer MJ, Dickson DW, Wszolek ZK, Hattori N, Tsuboi Y. Establishing diagnostic criteria for Perry syndrome. J Neurol Neurosurg Psychiatry. pii: jnnp-2017-316864, 2017 |
|
|
Miyamoto N, Tanaka R, Ueno Y, Watanabe M, Kurita N, Hira K, Shimada Y, Kuroki T, Yamashiro K, Urabe T, Hattori N: Analysis of the usefulness of the WORSEN score for predicting the deterioration of acute ischemic stroke. J Stroke Cerebrovasc Dis 26: 2834-2839, 2017 |
|
|
Mizuno Y, Hattori N, Kondo T, Nomoto M, Origasa H, Takahashi R, Yamamoto M, Yanagisawa N. A Randomized Double-Blind Placebo-Controlled Phase III Trial of Selegiline Monotherapy for Early Parkinson’s Disease．Clin Neuropharmacol, 40:201-207, 2017 |
|
|
Morishita T, Hilliard JD, Okun MS, Neal D, Nestor KA, Peace D, Hozouri AA, Davidson MR, Bova FJ, Sporrer JM, Oyama G, Foote KD. Postoperative lead migration in deep brain stimulation surgery: Incidence, risk factors, and clinical impact. PLoS One 12:e183711, 2017 |
|
|
Naito H, Takahashi T, Kamada M, Morino H, Yoshino H, Hattori N, Maruyama H, Kawakami H, Matsumoto M. First report of a Japanese family with spinocerebellar ataxia type 10: The second report from Asia after a report from China. PLoS One. 12:e0177955, 2017 |
|
|
Nakajima A, Oyama G, Jo T, Shimo Y, Umemura A, Nakajima M, Ishii H, Arai H, Hattori N. Rescue pallidal stimulation for diphasic and stimulation-induced dyskinesia after successful subthalamic stimulation for Parkinson's disease. Neurology and clinical neuroscience 5:127-128 2017 |
|
|
Nakajima A, Shimo Y, Uka T, Hattori N. Subthalamic nucleus and globus pallidus interna influence firing of tonically active neurons in the primate striatum through different mechanisms. Eur J Neurosci. 46:2662-2673, 2017 |
|
|
Nakashima Y, Ohta S, Wolf AM.: Blue light-induced oxidative stress in live skin. Send to Free Radic Biol Med. 108:300-310, 2017 |
|
|
Nakayama S, Suda A, Nakanishi A, Motoi Y, Hattori N. Galantamine Response Associates with Agitation and the Prefrontal Cortex in Patients with Alzheimer's Disease. J Alzheimers Dis. 57:267-273, 2017 |
|
|
Nishioka K, Fujimaki M, Kanai K, Ishiguro Y, Nakazato T, Tanaka R, Yokoyama K, Hattori N. Demyelinating Peripheral Neuropathy Due to Renal Cell Carcinoma. Intern Med. 56:101-104, 2017 |
|
|
Nishioka K, Kanai K, Hattori N. Paraneoplastic neuromyotonia due to lung carcinoma and invisible muscle cramps evaluated using ultrasonography. J Neurooncol. 134:243-244, 2017
|
|
|
Nishioka K, Uchida T, Usui C, Tanaka R, Matsushima T, Matsumoto Y, Nakamura I, Nishioka K, Hattori N. High prevalence of anti-TSH receptor antibody in fibromyalgia syndrome. Int J Rheum Dis. 20:685-690, 2017 |
|
|
Okamoto S, Murano T, Suzuki T, Uematsu S, Niwa Y, Sasazawa Y, Dohmae N, Bujo H, Simizu S. Regulation of secretion and enzymatic activity of lipoprotein lipase by C-mannosylation. Biochem. Biophys. Res. Commun. 486:558-563, 2017 |
|
|
Ono T, Kamimura N, Matsuhashi T, Nagai T, Nishiyama T, Endo J, Hishiki T, Nakanishi T, Shimizu N, Tanaka H, Ohta S, Suematsu M, Ieda M, Sano M, Fukuda K, Kaneda R: The histone 3 lysine 9 methyltransferase inhibitor chaetocin improves prognosis in a rat model of high salt diet-induced heart failure. Sci Rep. 7:39752, 2017 |
|
|
Ouma S, Fukae J, Fujioka S, Yamamoto S, Hatano T, Yoritaka A, Okuma Y, Kashihara KI, Hattori N, Tsuboi Y. The Risk Factors for the Wearing-off Phenomenon in Parkinson's Disease in Japan: A Cross-sectional, Multicenter Study. Intern Med. 56:1961-1966, 2017 |
|
|
Puschmann A, Fiesel FC, Caulfield TR, Hudec R, Ando M, Truban D, Hou X, Ogaki K, Heckman MG, James ED, Swanberg M, Jimenez-Ferrer I, Hansson O, Opala G, Siuda J, Boczarska-Jedynak M, Friedman A, Koziorowski D, Rudzinska-Bar M, Aasly JO, Lynch T, Mellick GD, Mohan M, Silburn PA, Sanotsky Y, Vilariño-Güell C, Farrer MJ, Chen L, Dawson VL, Dawson TM, Wszolek ZK, Ross OA, Springer W. Heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorder. Brain, 140:98-117, 2017 |
|
|
Saiki S, Hatano T, Fujimaki M, Ishikawa KI, Mori A, Oji Y, Okuzumi A, Fukuhara T, Koinuma T, Imamichi Y, Nagumo M, Furuya N, Nojiri S, Amo T, Yamashiro K, Hattori N. Decreased long-chain acylcarnitines from insufficient beta-oxidation as potential early diagnostic markers for Parkinson’s disease. Sci Rep, 7:7328, 2017 |
|
|
Sato K, Kerever A, Kamagata K, Tsuruta K, Irie R, Tagawa K, Okazawa H, Arikawa-Hirasawa E, Nitta N, Aoki I, Aoki S. Understanding microstructure of the brain by comparison of neurite orientation dispersion and density imaging (NODDI) with transparent mouse brain. Acta Radiol Open. 2017 Apr 17;6(4):2058460117703816 |
|
|
Sato S, Li Y, Hattori N. Lysosomal defects in ATP13A2 and GBA associated familial Parkinson's disease, J Neural Transm (Vienna), 124: 1395-1400, 2017 |
|
|
Sadatsuki R, Kaneko H, Kinoshita M, Futami I, Nonaka R, Culley KL, Otero M, Hada S, Goldring MB, Yamada Y, Kaneko K, Arikawa-Hirasawa E, Ishijima M. Perlecan is required for the chondrogenic differentiation of synovial mesenchymal cells through regulation of Sox9 gene expression. J Orthop Res. 35:837-846, 2017 |
|
|
Sekimoto S, Oyama G, Izawa N, Ueno S, Jo T, Shimo Y, Nakajima A, Nakajima M, Umemura A, Arai H, Hattori N:Effect of zonisamide on post-traumatic Holmes' tremor. Neurology and clinical Neuroscience 5:184, 2017 |
|
|
Sekimoto S, Oyama G, Jo T, Nakajima A, Shimo Y, Nakajima M, Umemura A, Ito M, Arai H, Hattori N. "Two odd targets" strategy in deep brain stimulation for Parkinson's disease with unilateral levodopa-induced dystonia. Neurology and clinical neuroscience 5:129-130, 2017 |
|
|
Shiba-Fukushima K, Ishikawa K-I, Inoshita T, Izawa N, Takanashi M, Sato S, Onodera O, Akamatsu W, Okano H, Imai Y, Hattori N: Evidence that phosphorylated ubiquitin signaling is involved in the etiology of Parkinson’s disease Hum Mol Genet. 26: 3172-3185, 2017 |
|
|
Shimura H, Tanaka R, Shimada Y, Yamashiro K, Hattori N, Urabe T. Glycyl-alanyl-histidine protects PC12 cells against hydrogen peroxide toxicity. BMC Biochem. 18:14, 2017 |
|
|
Straniero L, Guella I, Cilia R, Parkkinen L, Rimoldi V, Young A, Asselta R, Soldà G, Sossi V, Stoessl AJ, Priori A, Nishioka K, Hattori N, Follett J, Rajput A, Blau N, Pezzoli G, Farrer MJ, Goldwurm S, Rajput AH, Duga S. DNAJC12 and dopa-responsive nonprogressive parkinsonism. Ann Neurol. 82:640-646, 2017 |
|
|
Suzuki K, Okuma Y, Uchiyama T, Miyamoto M, Sakakibara R, Shimo Y, Hattori N, Kuwabara S, Yamamoto T, Kaji Y, Hirano S, Kadowaki T, Hirata K; Kanto NMPD investigators. Impact of sleep-related symptoms on clinical motor subtypes and disability in Parkinson's disease: a multicentre cross-sectional study. J Neurol Neurosurg Psychiatry. 88:953-959, 2017 |
|
ページの先頭へ |
|
|
Suzuki K, Okuma Y, Uchiyama T, Miyamoto M, Sakakibara R, Shimo Y, Hattori N, Kuwabara S, Yamamoto T, Kaji Y, Hirano S, Numao A, Hirata K; Kanto NMPD investigators. Characterizing restless legs syndrome and leg motor restlessness in patients with Parkinson's disease: A multicenter case-controlled study. Parkinsonism Relat Disord. 44:18-22, 2017 |
|
|
Suzuki K, Okuma Y, Uchiyama T, Miyamoto M, Sakakibara R, Shimo Y, Hattori N, Kuwabara S, Yamamoto T, Kaji Y, Hirano S, Suzuki S, Haruyama Y, Kobashi G, Hirata K; Kanto NMPD investigators. The prevalence, course and clinical correlates of migraine in Parkinson's disease: A multicentre case-controlled study. Cephalalgia. 2017 Jan 1:333102417739302, 2017 |
|
|
Suzuki S, Akamatsu W, Kisa F, Sone T, Ishikawa KI, Kuzumaki N, Katayama H, Miyawaki A, Hattori N, Okano H. Efficient induction of dopaminergic neuron differentiation from induced pluripotent stem cells reveals impaired mitophagy in PARK2 neurons. Biochem Biophys Res Commun. 483:88-93, 2017 |
|
|
Takemura MY, Hori M, Yokoyama K, Hamasaki N, Suzuki M, Kamagata K, Kamiya K, Suzuki Y, Kyogoku S, Masutani Y, Hattori N, Aoki S. Alterations of the optic pathway between unilateral and bilateral optic nerve damage in multiple sclerosis as revealed by the combined use of advanced diffusion kurtosis imaging and visual evoked potentials, Magn Reson Imaging. 39:24-30, 2017 |
|
|
Takeshita Y, Shibata N, Kasanuki K, Nagata T, Shinagawa S, Kobayashi N, Ohnuma T, Suzuki A, Kawai E, Takayama T, Nishioka K, Motoi Y, Hattori N, Nakayama K, Yamada H, Arai H. Genetic association between RAGE polymorphisms and Alzheimer's disease and Lewy body dementias in a Japanese cohort: a case-control study. Int J Geriatr Psychiatry. 32:1241-1246, 2017 |
|
|
Taniguchi D, Oji Y, Ueno Y, Hirayama S, Fukui M, Miyamoto N, Yamashiro K, Tanaka R, Suzuki K, Hattori N. Limb-Shaking Transient Ischemic Attack Induced by Middle Cerebral Artery Dissection after Lung Surgery. J Stroke Cerebrovasc Dis. 26:e197-e198, 2017 |
|
|
Tsukada R, Oyama G, Shimo Y, Sekimoto S, Jo T, Nakajima A, Umemura A, Arai H, Hattori N : Interleaving stimulation with a combination of bipolar and monopolar configurations for secondary failure of bilateral subthalamic stimulation in Parkinson's disease. Neurology and clinical neuroscience 5:32-33 2017 |
|
|
Uchihara Y, Kataoka H, Yoshino H, Syobatake R, Hattori N, Ueno S. Parkin mutation may be associated with serious akinesia in a patient with Parkinson's disease. J Neurol Sci. 379:119-121, 2017 |
|
|
Ueno Y, Tanaka R, Yamashiro K, Miyamoto N, Hira K, Kurita N, Sakurai M, Urabe T, Shimada K, Miyazaki T, Daida H, Hattori N. Age Stratification and Impact of Eicosapentaenoic Acid and Docosahexaenoic Acid to Arachidonic Acid Ratios in Ischemic Stroke Patients. J Atheroscler Thromb. 2017 Dec 2, |
|
|
Wang L, Heckman MG, Aasly JO, Annesi G, Bozi M, Chung SJ, Clarke C, CrosiersD, Eckstein G, Garraux G, Hadjigeorgiou GM, Hattori N, Jeon B, Kim YJ, Kubo M, Lesage S, Lin JJ, Lynch T, Lichtner P, Mellick GD, Mok V, Morrison KE, Quattrone A, Satake W, Silburn PA, Stefanis L, Stockton JD, Tan EK, Toda T, Brice A, Van Broeckhoven C, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Maraganore DM, Gasser T, Krüger R, Farrer MJ, Ross OA, Sharma M; GEOPD Consortium.. Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter study. Neurobiol Aging. 49:217.e1-217.e4, 2017 |
|
|
Yamada T, Kerever A, Yoshimura Y, Suzuki Y, Nonaka R, Higashi K, Toida T, Mercier F, Arikawa-Hirasawa E. Heparan sulfate alterations in extracellular matrix structures and fibroblast growth factor-2 signaling impairment in the aged neurogenic niche. J Neurochem. 142:534-544, 2017 |
|
|
Yamamoto H, Arimura S, Nakanishi A, Shimo Y, Motoi Y, Ishiguro K, Murakami K, Hattori N, Aoki S. Age-related effects and gender differences in Japanese healthy controls for [(123)I] FP-CIT SPECT. Ann Nucl Med. 31:407-412, 2017 |
|
|
Yamashiro K, Tanaka R, Urabe T, Ueno Y, Yamashiro Y, Nomoto K, Takahashi T, Tsuji H, Asahara T, Hattori N. Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke. PLoS One. 12:e0171521, 2017 |
|
|
Yamashita C, Funayama M, Li Y, Yoshino H, Yamada H, Seino Y, Tomiyama H, Hattori N. Mutation screening of PLA2G6 in Japanese patients with early onset dystonia-parkinsonism. J Neural Transm (Vienna). 124:431-435, 2017 |
|
|
Yokoyama K, Cossu D, Hattori N. Mycobacterium avium subsp. paratuberculosis in Japanese MS, Clinical and experimental neuroimmunology 8:5,6, 2017 |
|
|
Yoritaka A, Abe T, Ohtsuka C, Maeda T, Hirayama M, Watanabe H, Saiki H, Oyama G, Fukae J, Shimo Y, Hatano T, Kawajiri S, Okuma Y, Machida Y, Miwa H, Suzuki C, Kazama A, Tomiyama M, Kihara T, Hirasawa M, Shimura H, Hattori N. Erratum to: A randomized double-blind multi-center trial of hydrogen water for Parkinson's disease: protocol and baseline characteristics. BMC Neurol. 17:35, 2017 |
|
|
Yoritaka A, Hattori N. Differences between responders and non-responders in Parkinson’s disease, Advance in Parkinson’s disease, DOI: 10.4236/apd.2017.62005, 2017 |
|
|
Yoshino H, Hirano M, Stoessl AJ, Imamichi Y, Ikeda A, Li Y, Funayama M, Yamada I, Nakamura Y, Sossi V, Farrer MJ, Nishioka K, Hattori N. Homozygous alpha-synuclein p.A53V in familial Parkinson's disease. Neurobiol Aging. 57:248.e7-248.e12, 2017 |
|
|
Youn J, Okuma Y, Hwang M, Kim D, Cho JW. Falling direction can predict the mechanism of recurrent falls in advanced Parkinson’s disease. Sci Rep. 7:3921, 2017 |
|
ページの先頭へ |
|
|
Fujimaki M, Kanai K, Funabe S, Takanashi M, Yokoyama K, Li Y, Hattori N. Parkinsonism in a patient with valosin-containing protein gene mutation showing: a case report. J Neurol. 264:1284-1286, 2017 |
|
|
Fukuda R, Miyamoto N, Hayashida A, Ueno Y, Yamashiro K, Tanaka R, Hattori N. Acute Hearing Loss Caused by Decreasing Anterior Inferior Cerebellar Arterial Perfusion in a Patient with Vertebral Artery Stenosis. J Stroke Cerebrovasc Dis. 26:e119-e121, 2017 |
|
|
Iwamuro H, Yanagawa T, Takamizawa S, Taniguchi M. Atypical findings of perineural cysts on postmyelographic computed tomography: a case report of intermittent intercostal neuralgia caused by thoracic perineural cysts. BMC Med Imaging 17:37, 2017 |
|
|
Kobayashi M, Nishioka K, Takanashi M, Hattori A, Shojima Y, Hayashida A, Sumii A, Ota T, Terao Y, Yokoyama K, Hattori N. Anti-NMDA receptor encephalitis due to large-cell neuroendocrine carcinoma of the uterus, J Neurol Sci. 383:72-74, 2017 |
|
|
Nakajima A, Oyama G, Jo T, Shimo Y, Umemura A, Nakajima M, Ishii H, Arai H, Hattori N. Rescue pallidal stimulation for diphasic and stimulation-induced dyskinesia after successful subthalamic stimulation for Parkinson's disease. Neurology and Clinical Neuroscience. 5:127-128, 2017 |
|
|
Nishioka K, Fujimaki M, Kanai K, Ishiguro Y, Nakazato T, Tanaka R, Yokoyama K, Hattori N.
Demyelinating Peripheral Neuropathy Due to Renal Cell Carcinoma, Intern Med. 56:101-104. 2017 |
|
|
Noda K, Hattori N, Okuma Y, Yamamoto T. Chronic subdural haematoma presenting as freezing of gait. BMJ Case Rep. 26;2017. pii: bcr-2017-221469, 2017 |
|
|
Sekimoto S, Oyama G, Jo T, Nakajima A, Shimo Y, Nakajima M, Umemura A, Ito M, Arai H, Hattori N. Two odd targets” strategy in deep brain stimulation for Parkinson's disease with unilateral levodopa-induced dystonia. Neurology and Clinical Neuroscience. 5: 129-130, 2017 |
|
|
Suehara Y, Imashimizu K, Miyamoto N, Uehara H, Tanabe Y, Hattori N, Suzuki K, Saito T, Kaneko K. Arterial Thoracic Outlet Syndrome and Cerebellar Infarction Following a Stress Fracture of the First Rib and Extensive Callus Formation: A Case Report, JBJS Case Connect. 7:e64, 2017 |
|
|
Taniguchi D, Nakajima S, Hayashida A, Kuroki T, Eguchi H, Machida Y, Hattori N, Miwa H. Deep cerebral venous thrombosis mimicking influenza-associated acute necrotizing encephalopathy: a case report. J Med Case Rep. 11:281, 2017 |
|
|
Taniguchi D, Oji Y, Ueno Y, Hirayama S, Fukui M, Miyamoto N, Yamashiro K, Tanaka R, Suzuki K, Hattori N. Limb-Shaking Transient Ischemic Attack Induced by Middle Cerebral Artery Dissection after Lung Surgery. J Stroke Cerebrovasc Dis, 26(10):e197-e198, 2017
Taniguchi D, Shimura H, Watanabe M, Hattori N, Urabe T. Widespread enlarged, perivascular spaces associated with dementia and focal brain dysfunction: case report. BMC Neurol. 17:210, 2017 |
|
|
Tsukada R, Oyama G, Shimo Y, Sekimoto S, Jo T, Nakajima A, Umemura A, Arai H, Hattori N. Interleaving stimulation with a combination of bipolar and monopolar configurations for secondary failure of bilateral subthalamic stimulation in Parkinson's disease. Neurology and Clinical Neuroscience. 5:32-33, 2017 |
|
|
Wallaert L, Hagiwara A, Andica C, Hori M, Yamashiro K, Koshino S, Maekawa T, Kamagata K, Aoki S. The advantage of SyMRI for the visualization of anterior temporal pole lesions by double inversion recovery (DIR), phase-sensitive inversion recovery (PSIR), and myelin images in a patient with CADASIL. Magn Reson Med Sci, in press, 2017 |
|
ページの先頭へ |
|
|
梅村淳．脳深部刺激療法におけるIPG交換術後のデバイストラブル、機能的脳神経外科56:6-9, 2017 |
|
|
Umemura A, Shimo Y, Iwamuro H, Oyama G, Hattori N, Arai H. [Deep Brain Stimulation for Parkinson Disease:Mechanisms and New Technology], No Shinkei Geka, 45: 5-14, 2017 |
|
|
穂坂有加．パーキンソン病の発生メカニズムと治療、鍼灸127:7-12, 2017 |
|
|
横田淳一、山口洋子．小脳虫部中心に限局性の圧排所見を認めた後頭蓋窩髄膜腫例のENG検討 Equilibrium Res 76:17-25, 2017 |
|
|
横田淳一、石川景一、畠 将晃、山口洋子．頭位性めまいを主訴とした脊髄小脳失調症6型（SCA6)例のENG検討、Equilibrium Res 76:162-173, 2017 |
|
|
横田淳一、天草弥生One-and-a-half症候群発症後に後天性振子様眼振・上肢ミオクローヌス・オリーブ核肥大など多彩な症状が続発した橋出血例、Equilibrium Res 76:674-683, 2017 |
|
|
頼高朝子、布施木景子．統合失調症に合併したパーキンソン病症例の臨床的特徴、前方向的観察、初年度報告、平成28年度順天堂精神医学研究所紀要、94-97, 2017 |
|
ページの先頭へ |
|
|
小倉玄睦、深江治郎、木村 聡、青木光希子、鍋島一樹、坪井義夫．壊死性網膜壊死を合併しアシクロビル抵抗性を示した単純ヘルペス脳炎、臨床神経学 57:230-233、2017 |
|
ページの先頭へ |
|
|
｜入局・研修希望の方｜受診希望の方｜患者さん向け情報｜医療関係者の方｜
